查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392096

临床诊断市场：依产品类型、最终使用者类型、应用、地区

Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球临床诊断市场规模为1,044.7亿美元，2023年至2030年年复合成长率（CAGR）为13.8%，预计2030年将达到2,582.1亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 1044.7亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 13.80% 2030年市场规模预测 2582.1亿美元
图 1. 2023 年按地区分類的临床诊断全球市场占有率(%)
医师办公室诊断市场-IMG1

POCT 可实现快速、准确的诊断测试并立即提供结果，帮助医生和患者尽快远端做出治疗决策。为了协助诊断、监测和管理各种医疗状况，医生办公室、诊所和门诊诊所使用各种被归类为「诊所诊断」的医疗设备、装置和测试。这些诊断对于快速且准确的医疗决策、改善病患治疗结果以及提高医疗保健服务的有效性至关重要。

市场动态

对现场检测的需求不断增长、对预防性医疗保健的重视以及诊断设备的技术进步预计将在预测期内推动全球临床诊断市场的成长。此外，对个人化医疗的日益关注预计也将推动预测期内全球医疗诊断市场的成长。床边检测的扩展、分子诊断的进步、数位健康解决方案的整合以及新兴市场的扩展预计将为预测期内的全球临床诊断市场提供成长机会。

然而，监管和合规挑战、技术复杂性和操作员技能预计将阻碍预测期内全球临床诊断市场的成长。

本研究的主要特点

  • 该报告对全球临床诊断市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球医师办公室诊断市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球临床诊断市场的各种策略矩阵，将有助于相关人员做出决策。

目录

第1章研究目的与前提

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第4章全球临床诊断市场－冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章全球临床诊断市场，依产品类型，2018-2030

  • 即时检测 (POCT) 设备
  • 临床生化分析仪
  • 免疫检测系统
  • 分子诊断
  • 尿液检查系统

第6章全球临床诊断市场，依最终使用者类型，2018-2030

  • 医务室/诊所
  • 急诊中心
  • 门诊治疗中心

第7章全球临床诊断市场（按应用），2018-2030

  • 感染疾病
  • 心血管疾病
  • 代谢紊乱
  • 癌症诊断
  • 怀孕/生育力测试

第8章全球临床诊断市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Sysmex Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Ortho Clinical Diagnostics
  • Beckman Coulter, Inc.（a subsidiary of Danaher Corporation）
  • BioMerieux SA
  • Trinity Biotech plc
  • EKF Diagnostics Holdings plc

第10章章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6031

The Global Physician Office Diagnostic Market size was valued at US$ 104.47 billion in 2023 and is expected to reach US$ 258.21 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 13.8% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 104.47 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 13.80% 2030 Value Projection: US$ 258.21 Bn
Figure 1. Global Physician Office Diagnostic Market Share (%), by Region, 2023
Physician Office Diagnostic Market - IMG1

POCT enables quick and accurate diagnostic testing with immediate results, assisting doctors and patients in making decisions about care remotely and as soon as feasible. In order to help with the diagnosis, monitoring, and management of various medical diseases, physician offices, clinics, and ambulatory care facilities use a variety of medical devices, equipment, and tests that fall under the category of "physician office diagnostics." These diagnostics are essential for prompt and accurate medical decision-making, better patient outcomes, and increased healthcare delivery effectiveness.

Market Dynamics

Increasing demand for point-of-care testing, emphasis on preventive healthcare, and technological advancements in diagnostic devices are anticipated to drive growth of the global physician office diagnostic market over the forecast period. Moreover, increasing focus on personalized medicine is also expected to boost growth of the global physician office diagnostic market over the forecast period. Expansion of point-of-care testing, advances in molecular diagnostics and integration of digital health solutions, and expansion in emerging markets are expected to create growth opportunities for the global physician office diagnostic market during the forecast period.

However, regulatory and compliance challenges and technical complexity and operator skill are expected to hamper growth of the global physician office diagnostic market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global physician office diagnostic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global physician office diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Quidel Corporation, Hologic, Inc., Ortho Clinical Diagnostics, Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), BioMerieux SA, Trinity Biotech plc, EKF Diagnostics Holdings plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global physician office diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global physician office diagnostic market

Physician Office Diagnostic Market Detailed Segmentation:

  • By Product Type:
    • Point-of-Care Testing (POCT) Devices
    • Clinical Chemistry Analyzers
    • Immunoassay Systems
    • Molecular Diagnostics
    • Urinalysis Systems
  • By End User
    • Physician Offices and Clinics
    • Urgent Care Centers
    • Ambulatory Care Centers
  • By Application
    • Infectious Diseases
    • Cardiovascular Disorders
    • Metabolic Disorders
    • Cancer Diagnosis
    • Pregnancy and Fertility Testing
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • South Africa
  • Top companies in Physician Office Diagnostic Market
    • F.Hoffmann-La Roche Ltd
    • Siemens Healthineers AG
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sysmex Corporation
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Quidel Corporation
    • Hologic, Inc.
    • Ortho Clinical Diagnostics
    • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
    • BioMerieux SA
    • Trinity Biotech plc
    • EKF Diagnostics Holdings plc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Physician Office Diagnostic Market, By Product Type
    • Global Physician Office Diagnostic Market, By End User
    • Global Physician Office Diagnostic Market, By Application
    • Global Physician Office Diagnostic Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing demand for point-of-care testing
    • Regulatory and compliance challenges
    • Advancements in molecular diagnostics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Physician Office Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Physician Office Diagnostic Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Point-of-Care Testing (POCT) Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Clinical Chemistry Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Immunoassay Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Molecular Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Urinalysis Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Physician Office Diagnostic Market, By End User Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Physician Offices and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Urgent Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Ambulatory Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Global Physician Office Diagnostic Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Metabolic Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
  • Pregnancy and Fertility Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Global Physician Office Diagnostic Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region 2018 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Sub-region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sysmex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Quidel Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ortho Clinical Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Trinity Biotech plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • EKF Diagnostics Holdings plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us